In people with type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, responsible for regulating blood sugar and providing cells with glucose to produce energy. As a result, they ...
15 hours ago
0
6
In a paradigm-breaking study, researchers have discovered a novel way the immune system, specifically T cells, attack their target cells, reshaping long-held assumptions in immunology and demonstrating direct implications ...
Mar 24, 2026
0
312
A new study published in Neurology, led by Queen Mary University of London, has revealed that people of South Asian, African and European ancestry share many of the same genetic risk factors for multiple sclerosis (MS).
Mar 9, 2026
0
13
The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Researchers at the University Hospital Bonn (UKB) and the University ...
Feb 19, 2026
0
14
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has developed a novel cancer immunotherapy strategy that forces tumors to expose themselves to the immune ...
Jan 13, 2026
0
38
Genetic susceptibility to neurodevelopmental conditions such as schizophrenia, autism, and ADHD can be linked, in part, to distinct epigenetic signatures in newborn cord blood. An analysis of nearly 6,000 newborns published ...
Nov 17, 2025
0
15
Type 1 diabetes is an autoimmune disease in which the immune system destroys the body's own insulin-producing beta-cells in the pancreas, leaving patients with a lifelong dependency on external insulin.
Nov 6, 2025
0
24
Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative biology ...
Mar 10, 2025
0
43
In a new JAMA Dermatology study, scientists at King's College London found that changes in two parts of the genome work together to influence alopecia risk.
Feb 12, 2025
0
40
Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses.
Dec 13, 2024
0
40
